FAG
ZOM

Fortitude Advisory Group’s Zomedica Corp. ZOM Stock Holding History

Fortitude Advisory Group’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed – – 1442
2022
Q1 		$0 Hold
1,000
– – ﹤0.01% 1633
2021
Q4 		$0 Buy
+1,000
New +$450 ﹤0.01% 1570

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Fortitude Advisory Group's ZOM Position: Q2 2022 in Review

Fortitude Advisory Group sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 1,000 shares.

Fortitude Advisory Group first reported a position in ZOM in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

  • Fortitude Advisory Group reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
  • Fortitude Advisory Group sold 1,000 Zomedica Corp. shares in Q2 2022.
  • Fortitude Advisory Group first reported a position in Zomedica Corp. in Q4 2021 and held it in 2 quarters.
  • Fortitude Advisory Group's Zomedica Corp. position peaked at $0 in Q1 2022.
  • 97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.